Published in J Clin Oncol on February 01, 1984
Cardiotoxicity of anticancer treatments. Nat Rev Cardiol (2015) 2.28
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging (2014) 1.47
Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation. Int J Nanomedicine (2007) 1.37
The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract (2012) 1.36
Emerging paradigms in cardiomyopathies associated with cancer therapies. Circ Res (2013) 1.27
Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues. Circulation (2012) 1.14
Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling. J Cardiovasc Magn Reson (2013) 1.08
Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease. Br Heart J (1986) 1.08
Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs. J Nucl Cardiol (2012) 1.00
Non-invasive in vivo imaging of myocardial apoptosis and necrosis. Eur J Nucl Med Mol Imaging (2003) 0.99
Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines. Am J Cardiol (2012) 0.99
Running on empty: cardiovascular reserve capacity and late effects of therapy in cancer survivorship. J Clin Oncol (2012) 0.97
Exercise capacity in apparently healthy survivors of cancer. Arch Dis Child (2005) 0.92
Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Am J Cardiol (2012) 0.92
Chemotherapy-induced Cardiotoxicity. Maedica (Buchar) (2013) 0.88
Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling. Br Heart J (1988) 0.85
Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy. Breast Cancer Res Treat (2014) 0.84
Cardiovascular disease after cancer therapy. EJC Suppl (2014) 0.83
Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level. J Am Coll Cardiol (2015) 0.82
Enhanced Cardiac Testing in a Dual Anti-HER2 Regimen: What Have We Learned? Oncologist (2016) 0.82
Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms. Oncologist (2013) 0.82
Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs. Biomed Res Int (2015) 0.81
Cardiac dysfunction after cancer treatment. Tex Heart Inst J (2011) 0.80
Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After Chemotherapy. Am J Cardiol (2015) 0.79
Cardiac risk in the treatment of breast cancer: assessment and management. Breast Cancer (Dove Med Press) (2015) 0.78
Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential. Heart Fail Rev (2015) 0.77
Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study-A Single-Center, Blinded, Randomized Controlled Trial. Clin Cardiol (2016) 0.76
Phase I study of non-pegylated liposomal doxorubicin in combination with ifosfamide in adult patients with metastatic soft tissue sarcomas. Invest New Drugs (2009) 0.76
Cancer and cardiovascular disease: the use of novel echocardiography measures to predict subsequent cardiotoxicity in breast cancer treated with anthracyclines and trastuzumab. Curr Heart Fail Rep (2014) 0.75
Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance Imaging. Circ Cardiovasc Imaging (2016) 0.75
Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy. Int J Cardiovasc Imaging (2017) 0.75
Developing and implementing clinical practice guidelines. Qual Health Care (1995) 6.52
Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia (2011) 5.62
The effects of enalapril on hypertension and quality of life. A large multicenter study in Belgium. Acta Cardiol (1989) 2.66
Multivariate analysis of prognostic factors in metastatic breast cancer. J Clin Oncol (1983) 2.64
Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases. Cancer (1990) 2.56
Treatment of primary osteosarcoma with intra-arterial and intravenous high-dose methotrexate. J Clin Oncol (1983) 2.35
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32
The need for obtaining accurate nationwide estimates of diabetes prevalence in India - rationale for a national study on diabetes. Indian J Med Res (2011) 2.26
Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy. J Clin Oncol (1997) 2.25
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med (1997) 2.22
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer. J Clin Oncol (1997) 2.17
Neuroblastomas and neuroendocrine carcinomas of the nasal cavity: a proposed new classification. Cancer (1982) 2.16
Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer (1974) 2.10
Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer (2001) 1.89
The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab (1992) 1.86
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med (1982) 1.85
An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol (2012) 1.81
Intra-abdominal desmoplastic small cell tumor: a light microscopic, immunocytochemical, ultrastructural, and flow cytometric study. Hum Pathol (1993) 1.80
Polyclonal and monoclonal antibody and PCR-amplified small-subunit rRNA identification of a microsporidian, Encephalitozoon hellem, isolated from an AIDS patient with disseminated infection. J Clin Microbiol (1994) 1.80
LATCH: a breastfeeding charting system and documentation tool. J Obstet Gynecol Neonatal Nurs (1994) 1.79
Mechanical devices for arterial occlusion. Am J Roentgenol Radium Ther Nucl Med (1975) 1.72
Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum (2004) 1.71
Pleural mesothelioma: clinical features and therapeutic implications. Ann Intern Med (1977) 1.70
Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology (1981) 1.70
Granular cell tumor: a review of the pathology and histogenesis. Ultrastruct Pathol (1999) 1.67
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer (1995) 1.65
An epilepsy needs document. Seizure (1993) 1.64
The prevalence and location of metastases from ocular melanoma: imaging study in 110 patients. AJR Am J Roentgenol (1991) 1.63
Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res (1979) 1.62
Clinical pharmacology of sisomicin. Antimicrob Agents Chemother (1975) 1.61
Preoperative chemotherapy for soft-tissue sarcomas of the extremities. Ann Surg (1990) 1.59
Exercise testing in the evaluation of patients at high risk for complications from lung resection. Chest (1992) 1.59
Cooperation of structural proteins during late events in the life cycle of polyomavirus. J Virol (1993) 1.58
Natural history study of gallbladder cancer: a review of 36 years experience at M. D. Anderson Hospital and Tumor Institute. Cancer (1978) 1.53
A new and improved "quick-hot Gram-chromotrope" technique that differentially stains microsporidian spores in clinical samples, including paraffin-embedded tissue sections. Arch Pathol Lab Med (1997) 1.53
Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. Cancer Res (1998) 1.51
Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg (1986) 1.50
Vincristine neurotoxicity. Pathophysiology and management. Med Toxicol (1987) 1.48
Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cochrane Database Syst Rev (2001) 1.48
Is cardiotoxicity being adequately assessed in current trials of cytotoxic and targeted agents in breast cancer? Ann Oncol (2010) 1.48
Hormonal therapy of breast cancer: new approaches and concepts. Ann Intern Med (1978) 1.48
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol (2001) 1.47
Selective inhibition of in vitro DNA synthesis dependent on phiX174 compared with fd DNA. I. Protein requirements for selective inhibition. J Biol Chem (1977) 1.47
Vascular dysfunction after repair of coarctation of the aorta: impact of early surgery. Circulation (2001) 1.47
Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients. J Clin Oncol (1998) 1.46
Adriamycin cardiomyopathy--risk factors. Cancer (1977) 1.46
Endocrine and morphologic studies of pituitary adenomas secondary to primary hypothyroidism. J Clin Endocrinol Metab (1977) 1.46
Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol (1998) 1.45
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol (1999) 1.45
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45
Thymine ring saturation and fragmentation products: lesion bypass, misinsertion and implications for mutagenesis. Mutat Res (1993) 1.44
Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage renal disease. Cochrane Database Syst Rev (2001) 1.44
Therapeutic trials with tobramycin. Am J Med Sci (1974) 1.44
Segmentation of pulmonary nodules in thoracic CT scans: a region growing approach. IEEE Trans Med Imaging (2008) 1.44
Pharmacology of amikacin in humans. Antimicrob Agents Chemother (1974) 1.43
Gliomatosis cerebri in a 10-year-old girl masquerading as diffuse encephalomyelitis and spinal cord tumour. Dev Med Child Neurol (2001) 1.43
Tissue culture studies on pleural effusions from breast carcinoma patients. Cancer Res (1974) 1.42
Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Ann Oncol (2010) 1.42
Transcatheter occlusion of abdominal tumors. Radiology (1976) 1.41
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study. J Natl Cancer Inst (1991) 1.40
The role of adjuvant surgery in the combined modality therapy of small-cell bronchogenic carcinoma after a chemotherapy-induced partial remission. J Clin Oncol (1990) 1.40
Primary hepatic lymphoma in a patient with chronic hepatitis C. J Gastroenterol Hepatol (1994) 1.39
Chemotherapy and embolization via the inferior epigastric artery for the treatment of primary and metastatic cancer. AJR Am J Roentgenol (1989) 1.39
Intraluminal crystalloids in struma ovarii. Immunohistochemical, DNA flow cytometric, and ultrastructural study. Arch Pathol Lab Med (1991) 1.39
Combination chemotherapy in adult desmoid tumors. Cancer (1993) 1.36
Ewing's sarcoma and peripheral primitive neuroectodermal tumor: an interim report. Ann Otol Rhinol Laryngol (1996) 1.36
A randomized comparative trial of three aminoglycosides--comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies. Medicine (Baltimore) (1979) 1.36
Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Cancer Res (1977) 1.36
High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence. J Clin Oncol (1997) 1.34
Reproducibility and complications in gene searches: linkage on chromosome 6, heterogeneity, association, and maternal inheritance in juvenile myoclonic epilepsy. Am J Hum Genet (2000) 1.34
Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res (1999) 1.32
Establishment of epithelial cell line MDA-MB-157 from metastatic pleural effusion of human breast carcinoma. In Vitro (1977) 1.31
Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. Stroke (1995) 1.31
Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. Am J Med Genet (1999) 1.31
Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer (1999) 1.31
Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor. Cancer Chemother Pharmacol (2000) 1.31
Comparison of scintigraphy, sonography, and computed tomography in the evaluation of hepatic neoplasms. AJR Am J Roentgenol (1979) 1.30
Cancer of the right lobe of the liver: a variety of operative procedures. Arch Surg (1972) 1.30
Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol (1998) 1.29
Automated DNA sequencing and analysis of 106 kilobases from human chromosome 19q13.3. Nat Genet (1992) 1.29
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma. Ann Oncol (2006) 1.29
Systemic treatments for advanced cutaneous melanoma. Oncology (Williston Park) (1995) 1.29
Role of radiotherapy in sarcoma of the breast--a retrospective review of the M.D. Anderson experience. Radiother Oncol (1999) 1.29
Acanthamoeba healyi n. sp. and the isoenzyme and immunoblot profiles of Acanthamoeba spp., groups 1 and 3. J Protozool (1992) 1.28
Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience. Surgery (1994) 1.28
Short-term in vitro culture and molecular analysis of the microsporidian, Enterocytozoon bieneusi. J Eukaryot Microbiol (1995) 1.27
In vitro culture and serologic and molecular identification of Septata intestinalis isolated from urine of a patient with AIDS. J Clin Microbiol (1995) 1.27
Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases. Cancer (1992) 1.26
Angiographic classification of hepatic arterial collaterals. Radiology (1982) 1.26
Doxorubicin-induced congestive heart failure in adults. Cancer (1985) 1.26
Cardiotoxicity in patients receiving transtuzumab (Herceptin): primary toxicity, synergistic or sequential stress, or surveillance artifact? Semin Oncol (1999) 1.25
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer (1993) 1.25